Preclinical and experimental evidence of salvianolic acid B in the treatment of neurological diseases
BackgroundNeurological diseases such as stroke and Alzheimer’s disease pose increasing challenges to global public health. Salvianolic Acid B (SalB), a major active component of Salvia miltiorrhiza, has garnered attention due to its anti-inflammatory, antioxidant, neuroprotective, and pro-angiogenic...
Saved in:
Main Authors: | Shijun Bi, Shibing Liu, Kunyuan Zhu, Dandan Gao, Ligang Chen, Chunyong Yu, Guobiao Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1606146/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardio-protective effects of salvianolic acid B on oxygen and glucose deprivation (OGD)-treated H9c2 cells
by: Bin Yang, et al.
Published: (2019-12-01) -
Salvianolic Acid B Alleviates LPS-Induced Spleen Injury by Remodeling Redox Status and Suppressing NLRP3 Inflammasome
by: Hao Wang, et al.
Published: (2025-07-01) -
Association Between Thymosin β4 and Coronary Arterial Lesions in Children with Kawasaki Disease
by: Wu J, et al.
Published: (2025-07-01) -
Protective functions of salvianolic acid B in PC-12 cells against hydrogen peroxide-triggered damage by mediation of microRNA-26a
by: Niansheng Liu, et al.
Published: (2019-12-01) -
Lithium Chloride Effect on Mortality and Neurological Deficits in the Model of Ischemic Stroke in Rats
by: O. A. Grebenchikov, et al.
Published: (2022-01-01)